Less frequent subcutaneous dosing
Once or twice daily subcutaneous injection for treatment of venous thromboembolism and in unstable angina instead of intravenous infusion of high dose heparin.
No need for monitoring of the aPTT coagulation parameter as required for high dose heparin.
Possibly a smaller risk of bleeding
Smaller risk of osteoporosis in long-term use.
Smaller risk of heparin-induced thrombocytopenia, a potential side effect of heparin.
The anticoagulant effects of heparin are typically reversible with protamine sulfate, while protamine's effect on<unk>  is limited.
Low molecular weight heparin
Unfractionated heparin
Enoxaparin
Thrombolytics
Apixaban
Unfractionated heparin reversal
Fondaparinux
Anticoagulants